This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Institute of Pharmaceutical Industry. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovations of Mingyu Shi
Introduction
Mingyu Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on quinoline compounds. His research focuses on developing effective treatments for hyperlipidemia-related diseases.
Latest Patents
Mingyu Shi holds a patent for a quinoline compound and its pharmaceutical composition, preparation method, and uses. The invention discloses a quinoline compound represented by a specific formula, where various elements and groups are defined. This compound is designed to inhibit HMG-CoA reductase, which is crucial for treating diseases effectively. The patent highlights the compound's excellent lipid reduction effect in vivo, making it a valuable asset in the pharmaceutical industry.
Career Highlights
Mingyu Shi is affiliated with the Shanghai Institute of Pharmaceutical Industry, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating conditions related to lipid metabolism.
Collaborations
Mingyu Shi has collaborated with notable colleagues, including Zhengyan Cai and Weicheng Zhou. These partnerships have contributed to the advancement of his research and the development of innovative pharmaceutical solutions.
Conclusion
Mingyu Shi's contributions to the field of pharmaceuticals through his innovative quinoline compound patent demonstrate his commitment to addressing significant health challenges. His work continues to pave the way for advancements in medical treatments.